Providing Scientific Stewardship to the Healthcare Industry and Counsel.
On June 6th, 2019, the Antimicrobial Drugs Advisory Committee convened to discuss the new drug application. Read more
Innovative Science Solutions (ISS) is a consulting firm with over two decades of experience in the regulatory industry. Read more
Manufacturers, retailers, and distributors of e-cigarettes are likely to be defending themselves in against a variety of claims involving these products. Read more
Recently, both the U.S. House of Representatives and Senate held separate legislative hearings to address potential health and environmental impacts of pre-/polyfluorinated substances (PFAS). Read more
The causal relationship between smoking and lung cancer is one of the strongest and most well established in all the health sciences. Read more
Poly- and per-fluorinated alkyl substances (PFAS) are a group of synthesized chemicals that have been used for more than 50 years across many types of industries. Read more
Genetic knowledge continues to increase at a rapid pace, transforming not only the practice of medicine but also toxic tort litigation. Read more
In a recently published article, Guarrera and colleagues report differential DNA methylation between malignant pleural mesothelioma (MPM) patients and cancer-free controls. Read more
The volume of newly published scientific literature continues to grow at a staggering pace. Read more
A recent article by Marinaccio and colleagues examined gender differences and modalities of asbestos exposure in malignant mesothelioma (MM). Read more
Malic acid is a versatile ingredient that is commonly found in food and dietary supplement products. Lately, malic acid has become the target of a growing number of lawsuits. Read more
This article was co-written with William Wilt, President of Assured Research, a research and advisory firm dedicated to delivering highly customized, actionable research and analysis to insurance and investment professionals. Read more
A recently published article authored by Drs. Michele Carbone, Haining Yang, and Harvey Pass (among others) is relevant to asbestos and talc defendants because it provides additional data supporting the conclusion that inherited genetic variations cause mesothelioma in some persons without any known exposure to asbestos. Read more
A new paper by Kharazmi and colleagues present important data regarding the heritable nature of mesothelioma using epidemiological techniques to analyze the population-based Swedish Cancer Registry. Read more
An interesting new paper about the BRCA1 gene was published in the journal Nature last week (see here for a summary of the findings). Read more
This is our second comment on a very recent paper (Panou 2018) reporting findings from a study looking for germline (inherited) variants (mutations) in persons afflicted by mesotheliomas. Read more
As many of our readers know, there have been two recent, large toxic tort verdicts: (1) $4.6 billion talc verdict against J&J (22 ovarian cancer cases); and (2) $300 million glyphosate verdict against Monsanto. Read more
Some scientific findings provide both opportunities and risks for litigants in mass tort cases. Read more